CN111381540A - Control device applied to continuous blood glucose monitoring sensor - Google Patents
Control device applied to continuous blood glucose monitoring sensor Download PDFInfo
- Publication number
- CN111381540A CN111381540A CN202010195853.0A CN202010195853A CN111381540A CN 111381540 A CN111381540 A CN 111381540A CN 202010195853 A CN202010195853 A CN 202010195853A CN 111381540 A CN111381540 A CN 111381540A
- Authority
- CN
- China
- Prior art keywords
- module
- voltage
- blood glucose
- component
- control device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B19/00—Programme-control systems
- G05B19/02—Programme-control systems electric
- G05B19/04—Programme control other than numerical control, i.e. in sequence controllers or logic controllers
- G05B19/042—Programme control other than numerical control, i.e. in sequence controllers or logic controllers using digital processors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Optics & Photonics (AREA)
- Automation & Control Theory (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Emergency Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The application relates to the technical field of medical equipment, in particular to a control device applied to a continuous blood glucose monitoring sensor. The application provides a controlling means who is applied to continuous blood glucose monitoring sensor includes: a probe configured to receive a current signal from a blood glucose sensor, apply a voltage stimulus to the blood glucose sensor; an excitation module configured to apply a voltage excitation to the probe; the acquisition filtering module is configured to filter, amplify and send the signals from the probe to the processing control module; the processing control module is configured to control the data transmission module to send the processed current signal to a user display interface; the data transmission module is configured to send a current signal to a user display interface according to the instruction of the processing control module; the power supply module is configured to supply power to the excitation module, the acquisition filtering module, the processing control module and the data transmission module; a charging module configured to repeatedly charge the power supply module.
Description
Technical Field
The application relates to the technical field of medical equipment, in particular to a control device applied to a continuous blood glucose monitoring sensor.
Background
CGM (Continuous Glucose Monitoring) refers to a technique for indirectly reflecting blood Glucose concentration by continuously Monitoring the concentration of liquid Glucose in subcutaneous tissues. As a linear monitoring method, the CGM can provide continuous, comprehensive and reliable all-weather blood sugar information, hidden hyperglycemia and hypoglycemia which are difficult to detect by point monitoring can be easily found, the trend of blood sugar fluctuation can be known, and high and low blood sugar alarms are provided, so that the method has great clinical significance and value, is suitable for type 1 diabetes patients, type 2 diabetes patients treated by insulin, type 2 diabetes patients in perioperative period and the like, and is helpful for the patients to better control blood sugar and improve the quality of life.
Traditional venous blood glucose and glucometer tests can only reflect the instant blood glucose level and cannot reflect the complete blood glucose change and trend of patients. The continuous blood sugar monitoring system can monitor the dynamic change of blood sugar, can monitor the blood sugar change point and trend of a patient, and displays the complete blood sugar change map of the patient, so that a doctor can comprehensively know the blood sugar fluctuation type and the trend of the patient, and objective basis is provided for blood sugar control and diabetes treatment. Such as the discovery of unknown hyperglycemia and hypoglycemia, to more accurately assess and adjust the treatment regimen. The development and the application of the continuous blood sugar monitoring system can greatly make up the defects of an intermittent blood sugar meter, truly reflect the continuous blood sugar change condition of a patient, facilitate doctors and the patient to master the state of an illness at any time, provide scientific basis for better guiding the patient to take medicines, controlling diet and reasonably developing physical exercise, and can help the patient to establish a long-term blood sugar monitoring scheme and ensure that the blood sugar is controlled at a reasonable level.
However, the current continuous blood sugar monitoring equipment has the problems of low acquisition precision, inconvenient data transmission, incapability of recycling the blood sugar monitoring equipment, short service life, high equipment price and the like.
Disclosure of Invention
The application provides a be applied to controlling means of continuous blood sugar monitoring sensor, through setting up accurate excitation module, the collection filter module of low noise, the module of charging, power module, processing control module, data transmission module, the controlling means that can solve continuous blood sugar monitoring sensor to a certain extent gathers the precision not high, data transmission is inconvenient, blood sugar monitoring equipment can not reuse the problem that the life is short.
The embodiment of the application is realized as follows:
the embodiment of the application provides a controlling means who is applied to continuous blood glucose monitoring sensor, includes:
a probe configured to receive a current signal from a blood glucose sensor and apply a voltage stimulus to the blood glucose sensor;
an excitation module configured to apply a voltage excitation to the probe;
the acquisition filtering module is configured to filter and amplify the current signal from the probe and send the current signal to the processing control module;
the processing control module is configured to control the data transmission module to transmit the processed current signal to a user display interface;
the data transmission module is configured to send a current signal to a user display interface according to the instruction of the processing control module;
the power supply module is configured to supply power to the excitation module, the acquisition filtering module, the processing control module and the data transmission module;
a charging module configured to repeatedly charge the power supply module.
Optionally, the charging module is a wireless charging module.
Optionally, the charging module includes a coil assembly, an overvoltage protection assembly, a charging resonance assembly and a charging processing unit, and the overvoltage protection assembly controls a voltage from the coil assembly to be lower than a preset threshold voltage; the charging resonance component converts a voltage signal generated by the overvoltage protection component into a sinusoidal signal; and the charging processing unit rectifies the sinusoidal signal to generate a direct current signal.
Optionally, the power module includes a pre-stage filter assembly, a voltage step-up and step-down assembly, a post-stage filter assembly and a battery, and the current output by the battery passes through the pre-stage filter assembly, the voltage step-up and step-down assembly and the post-stage filter assembly, and the stable direct current required by the device is obtained through processing.
Optionally, the process control module is configured to: setting the device to operate in a low power mode; and if the monitoring data sent by the blood glucose sensor received by the device reaches the preset time threshold value, controlling the data transmission module to uniformly send the received monitoring data to a user display interface.
Optionally, the low power consumption mode comprises: closing interfaces and peripherals which are not used by the device; configuring a control pin of the apparatus in an analog signal input mode; setting the working current of the device to be 2uA-5 uA; and setting the monitoring time interval of the blood sugar sensor access to be 30-40 s.
Optionally, the excitation module includes an isolation component, a reference adjustment component, and a voltage reference component, and the voltage reference component generates a precision voltage excitation signal between 0.3V and 0.8V.
Optionally, the reference regulating component controls the voltage to be within an operating excitation range; the isolation assembly is used to improve the immunity to interference and drive capabilities applied to the probe voltage.
Optionally, the acquisition filtering module includes an input filtering component, a current-voltage conversion component, a voltage amplification component, and a front-end filtering component.
Optionally, the input filtering component performs low-pass filtering on the current signal from the probe to remove contact interference at the front end; the current signal after low-pass filtering is subjected to secondary low-pass filtering of the current-voltage conversion assembly, the voltage amplification assembly and the front-end filtering assembly, so that high-precision low-noise blood glucose sensor signal acquisition is realized.
The beneficial effect of this application lies in: through the arrangement of the charging module and the power supply module, the device can be charged and utilized again when the electric quantity of the battery is exhausted, and the device is utilized for multiple times; furthermore, accurate acquisition of the data acquired by the blood glucose sensor by the device can be realized through the arrangement of a precise excitation module and a low-noise acquisition filtering module; further, by processing the low power consumption setting of the control module, the working time of the device can be improved.
Drawings
In order to more clearly illustrate the embodiments of the present application or the technical solutions in the prior art, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below, and it is obvious that the drawings in the following description are some embodiments of the present application, and for those skilled in the art, other drawings can be obtained according to these drawings without inventive exercise.
FIG. 1 is a schematic diagram illustrating an acquisition control device of a continuous blood glucose monitoring sensor according to an embodiment of the present application;
FIG. 2 is a schematic diagram illustrating an excitation module and an acquisition filter module according to an embodiment of the present application;
FIG. 3 is a schematic diagram illustrating the operation of a process control module and a data transmission module according to an embodiment of the present application;
FIG. 4 is a schematic diagram illustrating the operation of a charging module and a power module according to an embodiment of the present application;
fig. 5 is a flow chart illustrating a low power consumption control method of a continuous blood glucose monitoring sensor according to an embodiment of the present application.
Detailed Description
To make the objects, technical solutions and advantages of the exemplary embodiments of the present application clearer, the technical solutions in the exemplary embodiments of the present application will be clearly and completely described below with reference to the drawings in the exemplary embodiments of the present application, and it is obvious that the described exemplary embodiments are only a part of the embodiments of the present application, but not all the embodiments.
All other embodiments, which can be derived by a person skilled in the art from the exemplary embodiments shown in the present application without inventive step, are within the scope of protection of the present application. Moreover, while the disclosure herein has been presented in terms of exemplary one or more examples, it is to be understood that each aspect of the disclosure can be utilized independently and separately from other aspects of the disclosure to provide a complete disclosure.
It should be understood that the terms "first," "second," "third," and the like in the description and in the claims of the present application and in the drawings described above are used for distinguishing between similar elements and not necessarily for describing a particular sequential or chronological order. It is to be understood that the data so used are interchangeable under appropriate circumstances and can be implemented in sequences other than those illustrated or otherwise described herein with respect to the embodiments of the application, for example.
Furthermore, the terms "comprises" and "comprising," as well as any variations thereof, are intended to cover a non-exclusive inclusion, such that a product or device that comprises a list of elements is not necessarily limited to those elements explicitly listed, but may include other elements not expressly listed or inherent to such product or device.
The term "component" as used herein refers to any known or later developed hardware, software, firmware, artificial intelligence, fuzzy logic, or combination of hardware and/or software code that is capable of performing the functionality associated with that element. .
Reference throughout this specification to "embodiments," "some embodiments," "one embodiment," or "an embodiment," or the like, means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, appearances of the phrases "in various embodiments," "in some embodiments," "in at least one other embodiment," or "in an embodiment" or the like throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments. Thus, the particular features, structures, or characteristics shown or described in connection with one embodiment may be combined, in whole or in part, with the features, structures, or characteristics of one or more other embodiments, without limitation. Such modifications and variations are intended to be included within the scope of the present application.
The present invention will now be described in detail with reference to the drawings and detailed description, which are illustrative of the invention and not restrictive.
Fig. 1 shows a schematic structural diagram of an acquisition control device of a continuous blood glucose monitoring sensor according to an embodiment of the present application.
The device comprises a probe 1, an excitation module 2, an acquisition filtering module 3, a charging module 4, a power supply module 5, a processing control module 6 and a data transmission module 7.
The blood glucose sensor is arranged on a human body and is connected with the device through the probe 1;
the excitation module 2 applies a voltage excitation to the blood glucose sensor through the probe 1, so as to activate the blood glucose sensor;
the acquisition filtering module 3 receives the current signal from the blood glucose sensor through the probe 1, performs filtering, conversion, amplification and acquisition processing, and then sends the current signal to the processing control module 6;
the processing control module 6 receives the current signal sent by the acquisition filtering module 3, and after the processing is finished, the data is transmitted back to the user through the data transmission module 7.
The power supply module 5 provides an operating power supply for the excitation module 2, the acquisition filtering module 3, the processing control module 6 and the data transmission module 7;
a charging module 4 configured to charge the power module 5 when the power of the power module is insufficient, so as to facilitate multiple uses of the device.
Fig. 2 shows a schematic working diagram of an excitation module and an acquisition filtering module according to an embodiment of the present application.
The probe 1 comprises two electrodes through which the excitation module 2 is connected to the probe 1; the signal input port of the acquisition filtering module 3 is connected to two electrodes of the probe 1.
The excitation module 2 includes an isolation assembly 21, a reference adjustment assembly 22, and a voltage reference assembly 23.
The excitation signal of the excitation module 2 may be implemented as a precision voltage of the order of 0.3V-0.8V, which is generated by the voltage reference component 23.
To ensure the accuracy of the voltage, the control of the regulated voltage by the reference regulation component 22 can be within the operating excitation range.
The voltage across the reference adjustment assembly passes through the isolation assembly 21, which can improve the immunity to interference and drive capability of the excitation, and then is applied to the probe 1.
The acquisition filtering module 3 comprises an input filtering component 31, a current-voltage conversion component 32, a voltage amplification component 33 and a front-end filtering component 34.
The signals collected by the probe 1 are weak current signals, and the signals are subjected to low-pass filtering through the input filtering component 31 to remove the contact interference at the front end.
The current signal is usually 0.1nA-20nA, the current signal is processed by the current-voltage conversion component 32 and the voltage amplification component 33, and then is subjected to secondary low-pass filtering by the front-end filtering component 34, and the generated low-noise signal is sent to the processing control module 6. This process achieves precise excitation generation and high-precision, low-noise signal acquisition.
Fig. 3 shows an operation diagram of a processing control module and a data transmission module according to an embodiment of the present application.
The processing control module 6 comprises a signal acquisition interface 61, an electric quantity acquisition interface 62, a data transmission interface 63, a communication power supply control interface 64 and a processing unit 65.
The processing unit 65 collects and processes the signals sent by the collection filtering module 3 through the signal collection interface 61. In some embodiments, the 12-bit ADC processor used is acquired,
the power consumption of the device is monitored through the power acquisition interface 62, and the processing unit 65 performs data interaction with the data transmission module 7 through the data transmission interface 63, wherein the interaction information includes connection verification, name transmission of the data transmission module 7, transmission of a communication connection mark and transmission of acquired data.
The data transmission module 7 includes a clock component 71, a matching circuit 72, an antenna component 73, and a data transmission control unit 74.
The operation and power supply of the data transmission module 7 are controlled by the processing control module 6. It can be embodied that the processing unit 64 controls the opening and closing of the data transmission module 7 through the communication power control interface 64.
The operation of the data transmission control unit 74 needs the clock component 71 to maintain, and data is transmitted to the outside through the matching circuit 72 and the antenna component 73. The matching circuit 72 and the antenna assembly 73 are also configured to accept external information including wakeup, broadcast name, connection and disconnection information, acquisition information of data, and the like.
Fig. 4 shows an operation schematic diagram of a charging module and a power module according to an embodiment of the present application.
The charging module 4 and the power supply module 5 provide stable power supply for the device. The device of the application has the advantage that the device can be charged for a plurality of times through the charging module 4, so that the device can be reused. In some embodiments, the device may be reused up to 300-500 times.
The charging module 4 includes a coil assembly 41, an overvoltage protection assembly 42, a charging resonance assembly 43, and a charging processing unit 44.
In some embodiments, the charging module 4 may be implemented as a wireless charging module, coupling the received electromagnetic energy through the coil assembly 41.
For safety protection of the charging process, an overvoltage protection component 42 is employed so that the voltage entering the device is below a preset threshold voltage. In some embodiments, the preset threshold voltage may be implemented as 6V.
Electromagnetic energy entering the device generates a regular sinusoidal signal through the charging resonance component 43, the frequency of which may be implemented in some embodiments as 100kHz-200 kHz.
The charging processing unit 44 rectifies the sinusoidal signal, generates a direct current signal, and charges the direct current signal into the battery 54.
In some embodiments, the charge level of the battery 54 may be detected by the process control module 6. When the electric quantity of the device is not enough to maintain the device to work, a low-electric-quantity alarm is sent through the data transmission module 7 to remind that the device needs to be charged.
The power module 5 comprises a pre-filtering component 51, a voltage step-up and step-down component 52, a post-filtering component 53 and a battery 54.
When the battery 54 is charged to maintain the normal operation of the device, the current from the battery 54 passes through the pre-filter 51, the voltage step-up/step-down 52 and the post-filter 53 to obtain the stable dc required by the device.
Fig. 5 is a flow chart illustrating a low power consumption control method of a continuous blood glucose monitoring sensor according to an embodiment of the present application.
The blood sugar continuous monitoring sensor realizes low-power-consumption blood sugar continuous monitoring through methods of access monitoring, data acquisition and data transmission time-sharing control.
First, the process control module sets the device to operate in a low power mode.
The low power consumption mode comprises the steps of closing an unused interface and peripheral equipment of the device, configuring a control pin of the device into an analog signal input mode, setting the working current of the device to be 2uA-5uA, and setting the monitoring time interval of the access of the blood glucose sensor to be 30s-40 s.
And if the device does not receive the data transmitted by the blood sugar sensor, continuously operating in the low power consumption mode.
And then, if the current signal sent by the blood glucose sensor received by the device reaches a preset time threshold value, controlling the data transmission module to intensively send the received current signal to a user display interface.
The device is configured to periodically monitor access of the blood glucose sensor, capture information by periodically controlling excitation and acquisition, and directly enter a low power consumption mode if no blood glucose sensor acquires a current signal or acquires data.
If the device monitors that a blood glucose sensor is accessed, the device starts to acquire current signals; after the current signal is acquired, the device continues to enter the low power consumption mode again to operate; the device continuously calculates the acquisition times of the current signals of the blood glucose sensor in the low power consumption mode; when the collection times of the current signals reach a preset time threshold, the processing control module 6 controls the data transmission module 7 to transmit data, and after data transmission is completed, the device continues to enter a low power consumption mode to operate.
By monitoring the access, acquisition and data transmission time-sharing control of the blood glucose sensor at regular time, the power consumption of the device can be effectively reduced, and the sampling precision and the data transmission stability of the device can be ensured. In some embodiments, the device can operate for 12-15 days with a battery capacity of 60-80 mAh by operating in the above low power mode.
The beneficial effect of this application lies in: through the arrangement of the charging module and the power supply module, the device can be charged and utilized again when the electric quantity of the battery is exhausted, and the device is utilized for multiple times; furthermore, accurate acquisition of the data acquired by the blood glucose sensor by the device can be realized through the arrangement of a precise excitation module and a low-noise acquisition filtering module; further, by processing the low power consumption setting of the control module, the working time of the device can be improved.
Moreover, those skilled in the art will appreciate that aspects of the present application may be illustrated and described in terms of several patentable species or situations, including any new and useful combination of processes, machines, manufacture, or materials, or any new and useful improvement thereon. Accordingly, various aspects of the present application may be embodied entirely in hardware, entirely in software (including firmware, resident software, micro-code, etc.) or in a combination of hardware and software. The above hardware or software may be referred to as "data blocks," modules, "" engines, "" units, "" components, "or" systems. Furthermore, aspects of the present application may be represented as a computer product, including computer readable program code, embodied in one or more computer readable media.
The computer storage medium may comprise a propagated data signal with computer program code embodied therewith, for example, on baseband or as part of a carrier wave. The propagated signal may take any of a variety of forms, including electromagnetic, optical, etc., or any suitable combination. A computer storage medium may be any computer-readable medium that can communicate, propagate, or transport a program for use by or in connection with an instruction execution system, apparatus, or device. Program code located on a computer storage medium may be propagated over any suitable medium, including radio, cable, fiber optic cable, RF, or the like, or any combination of the preceding.
Computer program code required for the operation of various portions of the present application may be written in any one or more programming languages, including an object oriented programming language such as Java, Scala, Smalltalk, Eiffel, JADE, Emerald, C + +, C #, VB.NET, Python, and the like, a conventional programming language such as C, Visual Basic, Fortran 2003, Perl, COBOL 2002, PHP, ABAP, a dynamic programming language such as Python, Ruby, and Groovy, or other programming languages, and the like. The program code may execute entirely on the user's computer, partly on the user's computer, as a stand-alone software package, partly on the user's computer and partly on a remote computer or entirely on the remote computer or server. In the latter scenario, the remote computer may be connected to the user's computer through any network format, such as a Local Area Network (LAN) or a Wide Area Network (WAN), or the connection may be made to an external computer (for example, through the Internet), or in a cloud computing environment, or as a service, such as a software as a service (SaaS).
Additionally, the order in which elements and sequences of the processes described herein are processed, the use of alphanumeric characters, or the use of other designations, is not intended to limit the order of the processes and methods described herein, unless explicitly claimed. While various presently contemplated embodiments of the invention have been discussed in the foregoing disclosure by way of example, it is to be understood that such detail is solely for that purpose and that the appended claims are not limited to the disclosed embodiments, but, on the contrary, are intended to cover all modifications and equivalent arrangements that are within the spirit and scope of the embodiments herein. For example, although the system components described above may be implemented by hardware devices, they may also be implemented by software-only solutions, such as installing the described system on an existing server or mobile device.
Similarly, it should be noted that in the preceding description of embodiments of the application, various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure aiding in the understanding of one or more of the embodiments. This method of disclosure, however, is not intended to require more features than are expressly recited in the claims. Indeed, the embodiments may be characterized as having less than all of the features of a single embodiment disclosed above.
The entire contents of each patent, patent application publication, and other material cited in this application, such as articles, books, specifications, publications, documents, and the like, are hereby incorporated by reference into this application. Except where the application is filed in a manner inconsistent or contrary to the present disclosure, and except where the claim is filed in its broadest scope (whether present or later appended to the application) as well. It is noted that the descriptions, definitions and/or use of terms in this application shall control if they are inconsistent or contrary to the statements and/or uses of the present application in the material attached to this application.
Claims (10)
1. A control device for use with a continuous blood glucose monitoring sensor, comprising:
a probe configured to receive a current signal from a blood glucose sensor and apply a voltage stimulus to the blood glucose sensor;
an excitation module configured to apply a voltage excitation to the probe;
the acquisition filtering module is configured to filter and amplify the current signal from the probe and send the current signal to the processing control module;
the processing control module is configured to control the data transmission module to send the processed current signal to a user display interface;
the data transmission module is configured to send a current signal to a user display interface according to the instruction of the processing control module;
the power supply module is configured to supply power to the excitation module, the acquisition filtering module, the processing control module and the data transmission module;
a charging module configured to repeatedly charge the power supply module.
2. The control device as claimed in claim 1, wherein the charging module is a wireless charging module.
3. The control device applied to the continuous blood glucose monitoring sensor as claimed in claim 1, wherein the charging module comprises a coil component, an overvoltage protection component, a charging resonance component and a charging processing unit,
the overvoltage protection component controls the voltage from the coil component to be lower than a preset threshold voltage;
the charging resonance component converts a voltage signal generated by the overvoltage protection component into a sinusoidal signal;
and the charging processing unit rectifies the sinusoidal signal to generate a direct current signal.
4. The control device as claimed in claim 1, wherein the power module comprises a pre-filter, a voltage-up-and-down-filter, a post-filter, and a battery,
and the current output by the battery passes through the filtering components at the front stage, the voltage boosting and reducing components and the filtering components at the rear stage to obtain the stable direct current required by the device.
5. The control device as claimed in claim 1, wherein the process control module is configured to:
setting the device to operate in a low power mode;
and if the monitoring data sent by the blood glucose sensor received by the device reaches the preset time threshold value, controlling the data transmission module to uniformly send the received monitoring data to a user display interface.
6. The control device as claimed in claim 5, wherein the low power mode comprises:
closing interfaces and peripherals which are not used by the device;
configuring a control pin of the apparatus in an analog signal input mode;
setting the working current of the device to be 2uA-5 uA;
and setting the monitoring time interval of the blood sugar sensor access to be 30-40 s.
7. The control device as claimed in claim 1, wherein the excitation module comprises an isolation component, a reference adjustment component, a voltage reference component, and the voltage reference component generates a precision voltage excitation signal between 0.3V and 0.8V.
8. The control device for a continuous blood glucose monitoring sensor of claim 7,
the reference regulating component controls the voltage to be within a working excitation range;
the isolation assembly is used to improve the immunity to interference and drive capabilities applied to the probe voltage.
9. The control device as claimed in claim 1, wherein the collection filter module comprises an input filter module, a current-to-voltage conversion module, a voltage amplification module, and a front-end filter module.
10. The control device for a continuous blood glucose monitoring sensor of claim 9,
the input filtering component performs low-pass filtering on a current signal from the probe to remove contact interference at the front end;
the current signal after low-pass filtering is subjected to secondary low-pass filtering of the current-voltage conversion assembly, the voltage amplification assembly and the front-end filtering assembly, so that high-precision low-noise blood glucose sensor signal acquisition is realized.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010195853.0A CN111381540A (en) | 2020-03-19 | 2020-03-19 | Control device applied to continuous blood glucose monitoring sensor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010195853.0A CN111381540A (en) | 2020-03-19 | 2020-03-19 | Control device applied to continuous blood glucose monitoring sensor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111381540A true CN111381540A (en) | 2020-07-07 |
Family
ID=71217197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010195853.0A Pending CN111381540A (en) | 2020-03-19 | 2020-03-19 | Control device applied to continuous blood glucose monitoring sensor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111381540A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111991003A (en) * | 2020-08-12 | 2020-11-27 | 上海萌草科技有限公司 | Savitzky-Golay filtering-based continuous blood glucose smoothing method, device, equipment and storage medium |
| CN112311189A (en) * | 2020-10-16 | 2021-02-02 | 南京风兴科技有限公司 | Continuous blood sugar detector with manual electric energy rechargeable battery |
| CN113907752A (en) * | 2020-03-18 | 2022-01-11 | 上海移宇科技股份有限公司 | Mounting unit for analyte detection device |
| CN114699071A (en) * | 2022-06-06 | 2022-07-05 | 乐普（北京）医疗器械股份有限公司 | Continuous blood glucose monitor and applicator thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248984A (en) * | 2007-02-23 | 2008-08-27 | 株式会社日立制作所 | Information management system and information management server |
| WO2012127513A1 (en) * | 2011-03-24 | 2012-09-27 | Arnaldi E Gaetani Associati S.R.L. | Device for management and sampling of dialysis fluids for use with systems of the cgms type (continuous glucose monitoring systems) and the like |
| CN104055525A (en) * | 2014-06-20 | 2014-09-24 | 中国科学院苏州生物医学工程技术研究所 | Implantable type low-consumption wireless blood glucose monitor |
| CN105529802A (en) * | 2014-09-29 | 2016-04-27 | 南京德朔实业有限公司 | Charging system |
| CN106264522A (en) * | 2015-05-15 | 2017-01-04 | 南京锐达金电子科技有限公司 | A kind of Noninvasive Blood Glucose Detection Methods based on Bioelectrical impedance analysis and device thereof |
| CN108078569A (en) * | 2016-11-21 | 2018-05-29 | 南通九诺医疗科技有限公司 | The Dynamic Blood Glucose Monitoring instrument and its control method of a kind of cell phone application direct monitoring |
| CN108078570A (en) * | 2016-11-21 | 2018-05-29 | 南通九诺医疗科技有限公司 | The Dynamic Blood Glucose Monitoring circuit and its control method of a kind of built-in acceleration sensor |
| CN110638467A (en) * | 2018-06-27 | 2020-01-03 | 中国医学科学院生物医学工程研究所 | Method and system for detecting blood sugar of experimental animal |
-
2020
- 2020-03-19 CN CN202010195853.0A patent/CN111381540A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101248984A (en) * | 2007-02-23 | 2008-08-27 | 株式会社日立制作所 | Information management system and information management server |
| WO2012127513A1 (en) * | 2011-03-24 | 2012-09-27 | Arnaldi E Gaetani Associati S.R.L. | Device for management and sampling of dialysis fluids for use with systems of the cgms type (continuous glucose monitoring systems) and the like |
| CN104055525A (en) * | 2014-06-20 | 2014-09-24 | 中国科学院苏州生物医学工程技术研究所 | Implantable type low-consumption wireless blood glucose monitor |
| CN105529802A (en) * | 2014-09-29 | 2016-04-27 | 南京德朔实业有限公司 | Charging system |
| CN106264522A (en) * | 2015-05-15 | 2017-01-04 | 南京锐达金电子科技有限公司 | A kind of Noninvasive Blood Glucose Detection Methods based on Bioelectrical impedance analysis and device thereof |
| CN108078569A (en) * | 2016-11-21 | 2018-05-29 | 南通九诺医疗科技有限公司 | The Dynamic Blood Glucose Monitoring instrument and its control method of a kind of cell phone application direct monitoring |
| CN108078570A (en) * | 2016-11-21 | 2018-05-29 | 南通九诺医疗科技有限公司 | The Dynamic Blood Glucose Monitoring circuit and its control method of a kind of built-in acceleration sensor |
| CN110638467A (en) * | 2018-06-27 | 2020-01-03 | 中国医学科学院生物医学工程研究所 | Method and system for detecting blood sugar of experimental animal |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113907752A (en) * | 2020-03-18 | 2022-01-11 | 上海移宇科技股份有限公司 | Mounting unit for analyte detection device |
| WO2022007537A1 (en) * | 2020-03-18 | 2022-01-13 | 上海移宇科技股份有限公司 | Installation unit of analyte detection device |
| CN113907752B (en) * | 2020-03-18 | 2024-02-23 | 上海移宇科技股份有限公司 | Mounting unit for analyte detection device |
| CN111991003A (en) * | 2020-08-12 | 2020-11-27 | 上海萌草科技有限公司 | Savitzky-Golay filtering-based continuous blood glucose smoothing method, device, equipment and storage medium |
| CN112311189A (en) * | 2020-10-16 | 2021-02-02 | 南京风兴科技有限公司 | Continuous blood sugar detector with manual electric energy rechargeable battery |
| CN114699071A (en) * | 2022-06-06 | 2022-07-05 | 乐普（北京）医疗器械股份有限公司 | Continuous blood glucose monitor and applicator thereof |
| CN114699071B (en) * | 2022-06-06 | 2022-08-23 | 乐普（北京）医疗器械股份有限公司 | Continuous blood glucose monitor's applier and blood glucose monitor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111381540A (en) | Control device applied to continuous blood glucose monitoring sensor | |
| KR102291849B1 (en) | Methods, systems and devices for calibration and optimization of glucose sensors and sensor outputs | |
| US20210236027A1 (en) | Dynamic blood glucose data acquiring device and host | |
| US20150194817A1 (en) | Integrated devices for low power quantitative measurements | |
| RU2707819C2 (en) | Analyte concentration determining kit | |
| US9913593B2 (en) | Low power device with variable scheduling | |
| US7756561B2 (en) | Method and apparatus for providing rechargeable power in data monitoring and management systems | |
| US20160081576A1 (en) | Low power device with contingent scheduling | |
| KR102367129B1 (en) | Implantable sensor and method for such sensor | |
| Benatti et al. | A sub-10mW real-time implementation for EMG hand gesture recognition based on a multi-core biomedical SoC | |
| US20090054747A1 (en) | Method and system for providing analyte sensor tester isolation | |
| CN105395192A (en) | Wearable emotion recognition method and system based on electroencephalogram | |
| JP6486964B2 (en) | Health management system | |
| US20170055890A1 (en) | Sensor module and kit for determining an analyte concentration | |
| JP7384800B2 (en) | continuous glucose monitoring system | |
| CN104055525A (en) | Implantable type low-consumption wireless blood glucose monitor | |
| CN113543698A (en) | Apparatus, system and method for user monitoring using electronic skin | |
| US20200054214A1 (en) | Learned monitoring device correction | |
| WO2022150665A1 (en) | Systems and methods for a personal medical monitoring device | |
| Jeyapriya et al. | Glucose monitoring and control in diabetes using GSM and automatic insulin injector system for human bodies | |
| US20210244957A1 (en) | Primates Depression Treatment Apparatus and Driving Method Thereof | |
| CN105517491A (en) | Continuous glucose monitoring system and monitoring terminal | |
| CN106073775A (en) | A kind of myoelectric signal collection apparatus and acquiring and processing method thereof | |
| CN215415184U (en) | Electrochemical sensor detection circuit, device and system | |
| US20190274570A1 (en) | Electroencephalogram detection device and equipment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200707 |
|
| RJ01 | Rejection of invention patent application after publication |